Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Georges Gemayel currently holds 10,787 shares of SUPERNUS PHARMACEUTICALS, INC. (SUPN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Georges Gemayel has been a net seller of SUPN stock. They have purchased $338.8K and sold $4.1M worth of shares.
Georges Gemayel's most recent insider trade was on Nov 8, 2024, when they sold 10,787 shares at $0.00 per share.
Georges Gemayel serves as Executive at SUPERNUS PHARMACEUTICALS, INC. (SUPN). They have executed 52 insider transactions totaling $4.5M over their tenure at the company.
Georges Gemayel holds the position of Executive at SUPERNUS PHARMACEUTICALS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Georges Gemayel has shown a selling trading pattern, with $338.8K in total purchases and $4.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Georges Gemayel was on Oct 30, 2007, when they sold $2.9M worth of GENZ shares. This transaction involved 37,500 shares at $76.00 per share.
Georges Gemayel currently owns 10,787 shares of SUPERNUS PHARMACEUTICALS, INC. (SUPN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Georges Gemayel's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Georges Gemayel has 52 Form 4 filings on record as an insider at SUPERNUS PHARMACEUTICALS, INC..
Set alerts for Georges Gemayel and 40,000+ other insiders.